WallStreetZenWallStreetZen

NASDAQ: ATNF
180 Life Sciences Corp Earnings & Revenue

ATNF earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$19.9M
Current Profit Margin
0%

ATNF Return on Equity

Current Company
-587.2%
Current Industry
-63.6%
Current Market
188%
ATNF's Return on Equity (-587.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ATNF announces earnings.

ATNF Return on Assets

Current Company
-205.5%
Current Industry
3%
ATNF is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ATNF Return on Capital Employed

Current Company
-11,297.22%
Current Industry
19.6%
ATNF's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ATNF vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ATNF$0.00-$22.13M-$19.94MN/AN/A
QLGN$4.62M-$16.39M-$17.34M+14.27%N/A
CNSP$0.00-$18.96M-$18.98MN/AN/A
ALLR$0.00-$11.28M-$20.42M-100.00%N/A
WINT$0.00-$25.64M-$24.83M-100.00%N/A

ATNF earnings dates

Next earnings date
May 13, 2024

180 Life Sciences Earnings & Revenue FAQ

What were ATNF's earnings last quarter?

On Invalid Date, 180 Life Sciences (NASDAQ: ATNF) reported Q4 2023 earnings per share (EPS) of $10.30, up 104.98% year over year. Total 180 Life Sciences earnings for the quarter were -$1.23 million. In the same quarter last year, 180 Life Sciences's earnings per share (EPS) was -$206.87.

If you're new to stock investing, here's how to buy 180 Life Sciences stock.

What was ATNF's earnings growth in the past year?

As of Q1 2024, 180 Life Sciences's earnings has grown year over year. 180 Life Sciences's earnings in the past year totalled -$19.94 million.

What is ATNF's earnings date?

180 Life Sciences's earnings date is Invalid Date. Add ATNF to your watchlist to be reminded of ATNF's next earnings announcement.

What was ATNF's revenue last quarter?

On Invalid Date, 180 Life Sciences (NASDAQ: ATNF) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, 180 Life Sciences's revenue was $0.00.

What was ATNF's revenue growth in the past year?

As of Q1 2024, 180 Life Sciences's revenue has grown null year over year. 180 Life Sciences's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.